Haemostasis unit, University Hospitals of Geneva
Geneva, 1205, Switzerland
NCT Number: NCT02329899
Observational study aimed at evaluating the clinical impact of a standardised diagnostic procedure for the investigation of patients with suspected mild bleeding disorder (MBD).
Looking for future studies?
Notify Me2 year and older
All sexes
Observational
Geneva, 1205, Switzerland
The working hypothesis of this prospective diagnostic study is that a standardised procedure in investigating patients with suspected MBD will lead to a better discrimination between patients with and without MBD and a more precise characterisation of MBD.
The primary objective of this diagnostic study is to evaluate the efficiency of a standardised procedure of MBD in children and adults referred to their respective outpatient clinics for bleeding symptoms. The following endpoints will be evaluated:
The secondary objective is to evaluate the bleeding events during a one-year follow-up. Follow-up will be performed with a phone call one year after the last consultation of the patient. The definition of a bleeding event will be any bleeding that promotes any specific medical attention (consultation, hospitalisation, transfusion, re-intervention in case of surgery). The detailed clinical history regarding each event will be collected. Bleeding events will be correlated to the clinical probability assessed at inclusion.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Second step according to results of the first step:
Time frame: after the completion of the standardized diagnostic procedure (on average 6 weeks after enrollment)
Diagnosis are going to be evaluated according to recognized classification of haemostatic disorders
Time frame: after the completion of the standardized diagnostic procedure (on average 6 weeks after enrollment)
Time frame: after the completion of the standardized diagnostic procedure (on average 1 week after enrollment in this low risk group)
Time frame: After one year follow-up
Phone call
University Hospital, Geneva
Other
Acronym: MBD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03734588
Adeno-Associated Virus (AAV), Blood Coagulation Disorder
Los Angeles, California, United States
View Trial DetailsNCT03876301
Blood Coagulation Disorder, Blood Coagulation Disorders
San Francisco, California, United States
View Trial DetailsNCT02856789
Blood Coagulation Disorders, Hematologic Diseases
Clamart, France
View Trial DetailsNCT01787552
Blood Coagulation Disorders, Blood Platelet Disorders
Camperdown, New South Wales, Australia
View Trial Details